ภาควิชาเวชศาสตร์ป้องกันและสังคม

1.

Nirdnoy N.; Sranacharoenpong K.; Surawit A.; Pinsawas B.; Mongkolsucharitkul P.; Pongkunakorn T.; Manosan T.; Ophakas S.; Suta S.; Pumeiam S.; Mayurasakorn K.; Ratanasuwan W.; Homsanit M.; Charoencholvanich K.; Suktitipat B.; Mitrpant C.; Pithukpakorn M.; Suriyaphol P.; Krittayaphong R.; Auewarakul P.; Tassaneetritap B.; Poungvarin N.

Validation of a Thai semiquantitative food frequency questionnaire (semi-FFQ) for people at risk of metabolic syndrome
Journal of Health, Population and Nutrition. 2023. 42 (1):

2.

Ogbuagu O.; Segal-Maurer S.; Ratanasuwan W.; Avihingsanon A.; Brinson C.; Workowski K.; Antinori A.; Yazdanpanah Y.; Trottier B.; Wang H.; Margot N.; Dvory-Sobol H.; Rhee M.S.; Baeten J.M.; Molina J.-M.

Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial
Lancet HIV. 2023. 10 (8): e497-e505.

3.

MacDonald D.M.; Samorodnitsky S.; Wendt C.H.; Baker J.V.; Collins G.; Kruk M.; Lock E.F.; Paredes R.; Poongulali S.; Weise D.O.; Winston A.; Wood R.; Kunisaki K.M.; Aagaard B.; Jansson P.O.; Pearson M.T.; Babiker A.G.; Arenas-Pinto A.; Atako N.B.; Dennis E.; Forcat S.; Hudson F.; Jackson B.; Maas D.; Purvis C.; Russell C.; Emery S.; Carey C.; Clewett M.; Jacoby S.; Gordin F.; Vjecha M.; Sanchez A.; Loria G.R.; Doldan M.L.; Moricz A.; Tillmann K.; Müller V.; Touloumi G.; Gioukari V.; Anagnostou O.; Herrero P.; Lopez P.; Avihingsanon A.; Rerksirikul P.; Loiza E.; Mingrone V.; Lupo S.; Marconi F.; Daniel D.; Crinejo A.; French M.; Barba L.; Rowling D.; Warzywoda E.; Bloch M.; Agrawal S.; Dwyer D.; Taylor J.; van Petersen L.; Mertens L.; De Wit S.; Kabamba K.; Wolff M.; Allendes G.; Ristola M.; Debham O.; Jessen H.; Jessen A.; Wiebecke S.; Klinker H.; Fätkenheuer G.; Lehmann C.; Knaevelsrud I.; Rittweger M.; Stöhr A.; Olah K.; Schaaf B.; Ratanasuwan W.; Werarak P.

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV
Scientific Reports. 2023. 13 (1):

4.

Song J.Y.; Choi W.S.; Heo J.Y.; Kim E.J.; Lee J.S.; Jung D.S.; Kim S.-W.; Park K.-H.; Eom J.S.; Jeong S.J.; Lee J.; Kwon K.T.; Choi H.J.; Sohn J.W.; Kim Y.K.; Yoo B.W.; Jang I.-J.; Capeding M.Z.; Roman F.; Breuer T.; Wysocki P.; Carter L.; Sahastrabuddhe S.; Song M.; D'Cor N.; Kim H.; Ryu J.H.; Lee S.J.; Park Y.W.; Cheong H.J.; Philippot A.; Solmi F.; Ceregido M.A.; Shim B.-S.; Seo S.H.; D'Souza S.; Thaisrivichai P.; Carlos J.; Alberto E.; Nitayaphan S.; Ratanasuwan W.; Mootsikapun P.; Chaiwarith R.; Chan Quang L.; Karpenko O.; Yurkiv T.; Kutovyi V.; Bartko A.; Gyrina O.; Barna O.; Pugach M.; Thurlow C.; Carson S.; Smith S.; Williams M.; Hemi Senior T.; Humphrey T.; Sheahan D.; Park H.; Lee Y.Y.; Kang S.G.

Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial
eClinicalMedicine. 2023. 64

5.

Orkin C.; Molina J.-M.; Cahn P.; Lombaard J.; Supparatpinyo K.; Kumar S.; Campbell H.; Wan H.; Teal V.; Jin Xu Z.; Asante-Appiah E.; Sklar P.; Avihingsanon A.; Kiertiburanakul S.; Ratanasuwan W.

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials
The Lancet HIV. 2023.

6.

Madsalae K, Ngamprasertchai T, Lawpoolsri S, Sirijatuphat R, Ratanasuwan W, Piyaphanee W, Pitisuttithum P.

Adherence and Health Problems in Thai Travellers Living with HIV
Trop Med Infect Dis. 2022. 7 (7):

7.

Chanwanichkulchai R., Homsanit M., Ratanasuwan W.

Effect of the COVID-19 Pandemic on Compliance with Contact and Droplet-precaution Measures in Siriraj Hospital’s Internal Medicine and Pediatrics Ward Nurses
Siriraj Medical Journal. 2022. 74 (6): 357-363.

8.

Avihingsanon A., Chetchotisakd P., Kiertiburanakul S., Ratanasuwan W., Siripassorn K., Supparatpinyo K., Martin H., Wang H., Wong T., Wang H.Y.

Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials
HIV Medicine. 2022.

9.

Sripanidkulchai K, Rattanaumpawan P, Ratanasuwan W, Angkasekwinai N, Assanasen S, Werarak P, Navanukroh O, Phatharodom P, Tocharoenchok T.

A Risk Prediction Model and Risk Score of SARS-CoV-2 Infection Following Healthcare-Related Exposure
Tropical Medicine and Infectious Disease. 2022. 7 (9):

10.

Changraksa N., Pannapoch L., Phatharodom P., Werarak P., Ratanasuwan W., Navanukroh O.

Occupational Post-exposure Prophylaxis after Blood and Body Fluids Exposure among Healthcare Workers in Siriraj Hospital
Siriraj Medical Journal. 2022. 74 (11): 787-791.

ภาควิชาเวชศาสตร์ป้องกันและสังคม

ผลงานที่ได้รับการตีพิมพ์

รศ.นพ. วินัย รัตนสุวรรณ